Two Sigma Securities LLC Takes Position in SPDR S&P Biotech ETF $XBI

Two Sigma Securities LLC purchased a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 3,610 shares of the exchange traded fund’s stock, valued at approximately $571,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in XBI. Northwestern Mutual Wealth Management Co. grew its position in SPDR S&P Biotech ETF by 145.7% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock worth $49,726,000 after acquiring an additional 186,314 shares during the last quarter. Marvin & Palmer Associates Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 80.1% during the second quarter. Marvin & Palmer Associates Inc. now owns 54,286 shares of the exchange traded fund’s stock valued at $8,591,000 after purchasing an additional 24,150 shares in the last quarter. Wellington Management Group LLP bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth about $19,270,000. Blue Edge Capital LLC bought a new stake in shares of SPDR S&P Biotech ETF during the second quarter worth about $851,000. Finally, First Bancorp Inc ME acquired a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $76,000.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $163.40 on Wednesday. The company has a 50 day simple moving average of $157.44 and a 200 day simple moving average of $139.75. The firm has a market cap of $10.67 billion, a PE ratio of 11.47 and a beta of 0.83. SPDR S&P Biotech ETF has a 1 year low of $91.10 and a 1 year high of $169.89.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.